Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors Mechelen, Belgium; October 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new in vitro pharmacological data from its selective TYK2 inhibitor, GLPG3667, currently in two Phase 3-enabling studies in dermatomyositis (DM) and systemic lupus erythematosus (SLE), at the American College of Rheumatology (ACR) Convergence 2025, taking place in Chicago, IL, October 24-29, 2025. The data show that the in vitro pharmacological ...
Galapagos presenteert in vitro-gegevens tijdens ACR Convergence 2025 die wijzen op differentiatie van GLPG3667 ten opzichte van andere TYK2-remmers Mechelen, België; 23 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag aangekondigd dat het nieuwe in vitro farmacologische gegevens zal presenteren van zijn selectieve TYK2-remmer, GLPG3667, die momenteel in twee fase 3-bepalende studies wordt onderzocht bij dermatomyositis (DM) en systemische lupus erythematodes (SLE), op het American College of Rheumatology (ACR) Convergence 2025, dat plaatsvindt in Chicago, Illino...
Aalberts: 3Q in line, FY margin now low end of guidance. Acomo: Going from strength to strength. Ahold Delhaize: New $860m distribution centre for Food Lion. Azelis: Weak 3Q25 as broadly expected, CFO to step down. Barco: Press release ahead of CMD. BE Semiconductor Industries: 3Q25 Results – Delivered on order intake. Econocom: 3Q25 organic growth down to c.3.4%, full year growth guidance confirmed. Heineken: EverGreen 2030. Kinepolis: Weak 3Q25 as expected, with Netherlands at ...
Heineken's EverGreen 2030 financial ambitions that will be presented further at today's CMD include a mid single digit organic net revenue growth with operating profit (beia) growing ahead, ao supported by € 400-500m annual gross savings. We believe these ambitions are not materially different from the EverGreen 2025 targets (4-8% operating profit beia growth) and are also incorporated in our forecasts. We still appreciate Heineken for the organic earnings growth potential, supported by ongoing ...
The Future of Beer is (Ever)Green! The Future of Beer is (Ever)Green! HEINEKEN unveils EverGreen 2030, its five-year strategy to accelerate growth Amsterdam, 23 October – HEINEKEN sees significant headroom for growth in the beer category, the company shall announce today at the unveiling of its EverGreen 2030 strategy despite the beer category's current sluggish recovery from COVID and inflationary-impacts. EverGreen is HEINEKEN’s sharpened five-year strategy to accelerate growth in a rapidly changing world. Changing consumer trends pose both challenges and new opportunities. Beer l...
AkzoNobel: 3Q25 in-line, FY guidance trimmed, €300m provision for Ichthys court case. Gimv: ImCheck Therapeutics checked out. Heineken: 3Q25 trading update; outlook FY25 slightly lowered. KPN: Ziggo 2Gbits internet roll out for c.7m homes by end 2025, full Netherlands by 2026. Randstad: 3Q25 result beats 5%; outlook 4Q25 also beats; strong OPEX performance
3Q beer volume dropped by 4.3% which was in line with our and consensus forecasts. Heineken now guides towards the low end of the 4-8% organic operating profit (beia) growth range for FY25 which is no surprise. We still appreciate Heineken for the organic earnings growth potential in the coming year, supported by ongoing cost savings and payback from gradually increasing marketing spend, but acknowledge that the bumpier volume evolution makes the investment case a bit more difficult. We look for...
Heineken N.V. reports on 2025 third quarter trading Amsterdam, 22 October 2025 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces Staying the course while navigating a challenging quarter Key Quarterly Highlights Revenue €8,712 million for the quarter, €25,636 million year to date Net revenue (beia) organically down 0.3% for the quarter, up 1.3% year to date Beer volume organically down 4.3% for the quarter, down 2.3% year to date Premium beer volume organically down 2.2% for the quarter, up 0.4% year to date Heineken® volume down 0.6% for the quarter, up 2.7% yea...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.